EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)

Mohd Adnan Kausar, Khalid Farhan Alshammari, Fahaad Alenazi, Sadaf Anwar, Amany Mohammed Khalifa, Tarig Ginawi, Abdulaziz Asiri, Mohammad Zeeshan Najm, Syed Arman Rabbani, Mohamed El-Tanani, Saumyatika Gantayat

International Journal of Oncology · 03.07.2025 · 67 (2) · 1-16

DOI: 10.3892/ijo.2025.5771 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, online erschienen am 03.07.2025. Verfasst von Mohd Adnan Kausar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, College of Medicine, University of Ha'il, Hail 2440, Saudi Arabia. Hauptthemen laut MEDLINE: Fanconi Anemia Complementation Group N Protein, Ovarian Neoplasms, Breast Neoplasms, Rad51 Recombinase. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fanconi Anemia Complementation Group N ProteinOvarian NeoplasmsBreast NeoplasmsRad51 RecombinaseHumansFemalePrecision MedicineMutationPoly(ADP-ribose) Polymerase InhibitorsBiomarkers, TumorHomologous Recombination

Stichwörter der Autor:innen

BRCAHRRPALB2PARP inhibitorsRAD51breast cancergenetic testingovarian cancertheragnostic

Substanzen

Fanconi Anemia Complementation Group N ProteinPALB2 protein, humanRad51 RecombinaseRAD51 protein, humanPoly(ADP-ribose) Polymerase InhibitorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biochemistry, College of Medicine, University of Ha'il, Hail 2440, Saudi Arabia.
  • Department of Internal Medicine, College of Medicine, University of Ha'il, Hail 2440, Saudi Arabia.
  • Department of Pharmacology, College of Medicine, University of Ha'il, Hail 2440, Saudi Arabia.
  • Department of Pathology, College of Medicine, University of Ha'il, Hail 2440, Saudi Arabia.
  • Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, Bisha 67714, Saudi Arabia.
  • School of Biosciences, Apeejay Stya University, Gurugram, Haryana 122103, India.

Zitieren

APA

Kausar, M. A., Alshammari, K. F., Alenazi, F., Anwar, S., Khalifa, A. M., Ginawi, T., Asiri, A., Najm, M. Z., Rabbani, S. A., El-Tanani, M., & Gantayat, S. (2025). RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review). International Journal of Oncology, 67(2), 1-16. https://doi.org/10.3892/ijo.2025.5771

Vancouver

Kausar MA, Alshammari KF, Alenazi F, Anwar S, Khalifa AM, Ginawi T, et al. RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review). International Journal of Oncology. 2025;67(2):1-16. doi:10.3892/ijo.2025.5771

BibTeX
@article{Kausar2025,
  author = {Kausar, Mohd Adnan and Alshammari, Khalid Farhan and Alenazi, Fahaad and Anwar, Sadaf and Khalifa, Amany Mohammed and Ginawi, Tarig and Asiri, Abdulaziz and Najm, Mohammad Zeeshan and Rabbani, Syed Arman and El-Tanani, Mohamed and Gantayat, Saumyatika},
  title = {RAD51 and PALB2 in precision oncology: Clinical implications for HRD associated breast and ovarian cancers (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  volume = {67},
  number = {2},
  pages = {1--16},
  doi = {10.3892/ijo.2025.5771}
}
Kostenlos starten →